Search for: "Bayer AG" Results 481 - 500 of 567
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Oct 2010, 1:47 am by Medical Library
An estimated 95% of cases occur in Asia and Africa and up to 60% of cases are in children under 15 years of age. [read post]
16 Jun 2011, 7:55 am by Josh Blackman
Seeing noreason for police officers or courts to blind themselves to that commonsense reality, we hold that a child’s age prop-erly informs the Miranda custody analysis. [read post]
25 Jul 2024, 3:03 pm by Kevin LaCroix
This will be particularly relevant in more recent proceedings, such as the claims against Bayer AG (arising from the Monsanto takeover and the Roundup risk) and against EY (arising from the Wirecard scandal). [read post]
1 Feb 2021, 11:27 am by Anastasiia Kyrylenko
Singh considers two cases, Bayer v Natco and Novartis AG v Union of India, to see how compulsory licensing of pharmaceuticals and evergreening of patents are dealt with by the Indian judiciary.Part VII “Lores of IP during wartime”Arpan Banerjee and Dana Beldiman, in Chapter 14, “International Trade Mark Enforcement Under the Versailles Treaty: A Case Study of Sanatogen”, discuss how the Bombay High Court applied IP-related provisions of the Versailles Treaty… [read post]
18 Oct 2010, 6:36 am by Holly Hayes
Of respondents age 55 and older, 60.5% said they’ve been sued once and 39.2% had been sued at least twice. [read post]
6 Aug 2024, 8:12 am by jonathanturley
He is the author of “The Indispensable Right: Free Speech in an Age of Rage” (Simon & Schuster). [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
2 Jun 2011, 3:42 am by Russell Jackson
The proposed Dry Max Diaper Settlement is a creative approach to the age-old problem of how to settle meritless class actions. [read post]
23 May 2011, 1:54 pm by FDABlog HPM
Bayer AG, et al., Case No. 10-762, which involved manufacturers of Ciprofloxacin HCl (CIPRO) and whether a particular patent settlement agreement was per se lawful under the Sherman Act. [read post]
5 Aug 2017, 5:13 am by Law Offices of Jeffrey S. Glassman
  This started with Xarelto, which is made by the German pharmaceutical giant, Bayer AG and its U.S. marketing partner Janssen (a Johnson & Johnson subsidiary) and then competitors Pradaxa, Eliquis, and eventually Savaysa. [read post]
17 Nov 2010, 1:48 am by Kelly
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No faultless… [read post]
25 Feb 2012, 11:15 am by Ed Wallis
Manufactured by Bayer Healthcare Pharmaceuticals, Inc., Mirena is an IUD device [intrauterine device] that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. [read post]
1 Apr 2011, 7:40 am
Mark your diaries for next week: there's an interesting-looking reference for a preliminary ruling by the Court of Justice in Europe from the Hoge Raad der Nederlanden in Case C-406/09 Realchemie Nederland BV v Bayer CropScience AG. [read post]
18 Jan 2011, 3:10 am by Scott A. McKeown
., 482 F.3d at 1319; see also Bayer AG, 298 F.3d at 1381. [read post]